Ralf Lorenz

2.3k total citations · 1 hit paper
44 papers, 1.1k citations indexed

About

Ralf Lorenz is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Ralf Lorenz has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Ralf Lorenz's work include Xenotransplantation and immune response (10 papers), Cancer Cells and Metastasis (10 papers) and Breast Cancer Treatment Studies (9 papers). Ralf Lorenz is often cited by papers focused on Xenotransplantation and immune response (10 papers), Cancer Cells and Metastasis (10 papers) and Breast Cancer Treatment Studies (9 papers). Ralf Lorenz collaborates with scholars based in Germany, Austria and United Kingdom. Ralf Lorenz's co-authors include Wolfgang Janni, Andreas Schneeweiß, Brigitte Rack, W. Lichtenegger, Peter A. Fasching, Tanja Fehm, Klaus Pantel, Thomas W. P. Friedl, Hans Tesch and Christian Schindlbeck and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Ralf Lorenz

43 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

2014 472 citations Brigitte Rack, Christian Schindlbeck et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralf Lorenz Germany	15	638	515	306	242	220	44	1.1k
Françoise Drusch France	14	544 0.9×	305 0.6×	114 0.4×	215 0.9×	195 0.9×	17	924
Yong Wen United States	17	485 0.8×	351 0.7×	70 0.2×	340 1.4×	263 1.2×	39	1.0k
Su Hwan Kang South Korea	14	452 0.7×	358 0.7×	155 0.5×	226 0.9×	160 0.7×	59	842
Jeremy Setton United States	20	368 0.6×	253 0.5×	431 1.4×	259 1.1×	424 1.9×	51	1.3k
Rüediger Liersch Germany	18	332 0.5×	216 0.4×	149 0.5×	438 1.8×	145 0.7×	33	942
C Sakakura Japan	17	267 0.4×	115 0.2×	363 1.2×	354 1.5×	308 1.4×	28	983
Gowtham Jayakumaran United States	11	237 0.4×	246 0.5×	114 0.4×	562 2.3×	275 1.3×	16	918
John B. Hamner United States	13	331 0.5×	227 0.4×	105 0.3×	367 1.5×	169 0.8×	27	849
A. Berchuck United States	21	337 0.5×	224 0.4×	181 0.6×	417 1.7×	141 0.6×	42	1.4k
Scott M. Weissman United States	13	242 0.4×	219 0.4×	226 0.7×	275 1.1×	86 0.4×	24	1.1k

Countries citing papers authored by Ralf Lorenz

Since Specialization

Citations

This map shows the geographic impact of Ralf Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lorenz more than expected).

Fields of papers citing papers by Ralf Lorenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lorenz. The network helps show where Ralf Lorenz may publish in the future.

Co-authorship network of co-authors of Ralf Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Lorenz. A scholar is included among the top collaborators of Ralf Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Lorenz. Ralf Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. Cancer Treatment Reviews. 121. 102631–102631. 6 indexed citations

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). 195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. ESMO Open. 8(1). 101384–101384. 1 indexed citations

Decker, Thomas, Nader Hirmas, Kristina Lübbe, et al.. (2023). Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA). The Breast. 72. 103575–103575. 4 indexed citations

Janni, Wolfgang, Thomas W. P. Friedl, Tanja Fehm, et al.. (2018). Abstract GS1-06: Extended adjuvant bisphosphonate treatment over five years in early breast cancer does not improve disease-free and overall survival compared to two years of treatment: Phase III data from the SUCCESS A study. Cancer Research. 78(4_Supplement). GS1–6. 9 indexed citations

Jueckstock, J, Brigitte Rack, Thomas W. P. Friedl, et al.. (2016). Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial. BMC Cancer. 16(1). 401–401. 14 indexed citations

Rack, Brigitte, H. Sommer, Wolfgang Janni, et al.. (2016). Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial. Geburtshilfe und Frauenheilkunde. 76(5). 542–550. 7 indexed citations

Rack, Brigitte, Julia Jückstöck, Elisabeth Trapp, et al.. (2016). CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients. Tumor Biology. 37(10). 13769–13775. 11 indexed citations

Hepp, Philip, Ulrich Andergassen, Bernadette Jäger, et al.. (2016). Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer – The SUCCESS Trial. Anticancer Research. 36(9). 4771–4776. 12 indexed citations

Rack, Brigitte, Christian Schindlbeck, Julia Jückstöck, et al.. (2014). Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 106(5). 472 indexed citations breakdown →

10.

Oskay-Özcelik, Gülten, Radoslav Chekerov, Karsten Münstedt, et al.. (2012). What do 676 primary and recurrent ovarian cancer (OC) patients expect from their doctors and therapy management? Results of a German survey of the northeastern German Society of Gynecological Oncology (NOGGO).. Journal of Clinical Oncology. 30(15_suppl). 5044–5044. 2 indexed citations

11.

Winkler, M, Michael Winkler, Martin Loss, et al.. (2005). Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model. Transplant International. 17(12). 848–858. 20 indexed citations

12.

Winkler, M, Michael Winkler, Martin Loss, et al.. (2004). Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model. Transplant International. 17(12). 848–858. 2 indexed citations

13.

Schultheiss, D., Ralf Lorenz, Heike Mertsching, et al.. (2004). Functional Tissue Engineering of Autologous Tunica Albuginea: A Possible Graft for Peyronie’s Disease Surgery. European Urology. 45(6). 781–786. 25 indexed citations

14.

Przemeck, Michael, Ralf Lorenz, B Vangerow, et al.. (2002). Pretreatment with C1-esterase inhibitor improves cardiovascular stability in small primates undergoing porcine kidney xenotransplantation. Transplantation Proceedings. 34(6). 2383–2383. 4 indexed citations

15.

Loss, M., et al.. (2001). Disorders of coagulation unrelated to xenograft rejection following pig-to-cynomolgus kidney transplantation. Transplantation Proceedings. 33(7-8). 3867–3868. 3 indexed citations

16.

Lorenz, Ralf, M. Loss, Jan Schmidtko, et al.. (2001). Influence of cold ischemia time on hyperacute rejection and delayed graft function of porcine kidneys following discordant xenotransplantation from pig to cynomolgus monkey. Transplantation Proceedings. 33(1-2). 740–741. 1 indexed citations

17.

Loss, M., Robert F. Kunz, Jan Schmidtko, et al.. (2001). Analysis of hematopoesis in cynomolgus recipients of h-CD55 transgenic or unmodified porcine kidneys. Transplantation Proceedings. 33(1-2). 736–737. 1 indexed citations

18.

Loss, M., Michael Przemeck, Jan Schmidtko, et al.. (2000). Factors determining the onset of hyperacute rejection following discordant porcine-to-cynomolgus monkey kidney xenotransplantation. Transplantation Proceedings. 32(5). 1098–1098. 1 indexed citations

19.

Loss, M., Robert F. Kunz, Michael Przemeck, et al.. (2000). INFLUENCE OF COLD ISCHEMIA TIME, PRETRANSPLANT ANTI-PORCINE ANTIBODIES, AND DONOR/RECIPIENT SIZE MATCHING ON HYPERACUTE GRAFT REJECTION AFTER DISCORDANT PORCINE TO CYNOMOLGUS KIDNEY TRANSPLANTATION. Transplantation. 69(6). 1155–1159. 25 indexed citations

20.

Rosenthal, Daniel, Gerhard Marquardt, Ralf Lorenz, & Michael Nichtweiß. (1996). Anterior decompression and stabilization using a microsurgical endoscopic technique for metastatic tumors of the thoracic spine. Journal of neurosurgery. 84(4). 565–572. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact